University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "Chester, J"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 9.


Karapanagiotou, EM, Roulstone, V, Twigger, K, Ball, M, Tanay, M, Nutting, C, Newbold, K, Gore, ME, Larkin, J, Syrigos, KN, Coffey, M, Thompson, B, Mettinger, K, Vile, RG, Pandha, HS, Hall, GD, Melcher, AA, Chester, J and Harrington, KJ (2012) Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies CLINICAL CANCER RESEARCH, 18 (7). pp. 2080-2089.

Kottke, T, Chester, J, Ilett, E, Thompson, J, Diaz, R, Coffey, M, Selby, P, Nuovo, G, Pulido, J and Mukhopadhyay, D (2011) Precise scheduling of chemotherapy primes VEGF-producing tumors for successful systemic oncolytic virotherapy. Mol Ther, 19 (10). pp. 1802-1812.

Kottke, T, Errington, F, Pulido, J, Galivo, F, Thompson, J, Wongthida, P, Diaz, RM, Chong, H, Ilett, E, Chester, J, Pandha, H, Harrington, K, Selby, P, Melcher, A and Vile, R (2011) Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors. Nat Med, 17 (7). pp. 854-859.

Karapanagiotou, EM, Chester, JD, Pandha, HS, Gill, GM, Coffey, MC, Mettinger, K and Harrington, KJ (2010) A phase I/II study of oncolytic reovirus plus carboplatin/paclitaxel in patients with advanced solid cancers with emphasis on squamous cell carcinoma of the head and neck(SCCHN) JOURNAL OF CLINICAL ONCOLOGY, 28 (15).

Kottke, T, Hall, G, Pulido, J, Diaz, RM, Thompson, J, Chong, H, Selby, P, Coffey, M, Pandha, H, Chester, J, Melcher, A, Harrington, K and Vile, R (2010) Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice JOURNAL OF CLINICAL INVESTIGATION, 120 (5). pp. 1551-1560.

Harrington, KJ, Vile, RG, Melcher, A, Chester, J and Pandha, HS (2010) Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics CYTOKINE & GROWTH FACTOR REVIEWS, 21 (2-3). pp. 91-98.

Conference or Workshop Item

Kottke, T, Donnelly, O, Boisgerault, N, Diaz, R, Thompson, J, Chester, J, Pandha, H, Harrington, K, Melcher, A and Vile, R (2012) Characterization of the Mechanisms of Tumor Dormancy and Recurrence Following Front Line Immuno-, Viro- or Suicide Gene-, Therapy In: 15th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), 2012-05-16 - 2012-05-19, Philadelphia, PA.

Karapanagiotou, E, Pandha, HS, Hall, G, Chester, J, Melcher, A, Coffey, M, de Bono, J, Gore, ME, Nutting, CM and Harrington, KJ (2009) Phase I/II trial of oncolytic reovirus (Reolysin) in combination with carboplatin/paclitaxel in patients (pts) with advanced solid cancers In: 45th Annual Meeting of the American-Society-of-Clinical-Oncology, 2009-05-29 - 2009-06-02, Orlando, FL.

Karapanagiotou, E, Pandha, H, Hall, G, Chester, J, Melcher, A, De Bono, J, Gore, M, Nutting, C and Harrington, K (2008) Phase I Trial of Oncolytic Reovirus (Reolysin) in Combination With Carboplatin/Paclitaxel in Patients With Advanced Solid Cancers In: 23rd Annual Scientific Meeting of the International-Society-for-Biological-Therapy-of-Cancer, 2008-10-31 - 2008-11-02, San Diego, CA.

This list was generated on Tue Jun 19 12:43:31 2018 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800